$0.41
▲ +7.2% Today
as of Oct 22, 16:46 ET
Last 30 days
Recent Press Releases & News
Biodexa Reaches 100-Patient Enrollment Milestone in Phase 3 Serenta Trial as Key Analysis Timeline Accelerates
Biodexa announces another Serenta milestone with 100 patients enrolled in its registrational Phase 3 trial in FAP
The Longview: Fireside Chat with Biodexa CEO Stephen Stamp
BDRX earnings at a glance
The share price of $0.41 sits near its 52-week low.
Overview
52-week range
$0.34
$45
0% of range
Avg surprise (last 0)
—
Avg reaction (last 0)
—
Earnings trends
Implied volatility — last 90 days
No IV snapshots yet for BDRX.
IV is captured twice daily (9:15 AM & 4:30 PM ET) for tickers with upcoming earnings. Comes online automatically once the next options refresh runs.